Page 1

BIOMARIN BioMarin Pharmaceutical Inc. Conference call to discuss U.S. approval of VOXZOGO ™ ( vosoritide ) for injection TM for the treatment of children with achondroplasia ages 5 years and older Jean - Jacques Bienaimé , Chairman and Chief Executive Officer